Your session is about to expire
← Back to Search
Resistance Exercise for Type 1 Diabetes
N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes
Awards & highlights
Study Summary
This trial will study how blood sugar responds to exercise at different times of day in people with type 1 diabetes.
Who is the study for?
This trial is for adults aged 18 to 55 with Type 1 diabetes diagnosed at least a year ago. It's not suitable for those with severe eye or nerve complications, recent changes in insulin management, high blood pressure, very high HbA1c levels, use of advanced insulin delivery systems, unpredictable low blood sugar episodes, or a history of heart disease.Check my eligibility
What is being tested?
The study is testing how the timing of resistance exercise (morning while fasted vs. afternoon) affects blood glucose levels in people with Type 1 diabetes. Participants will do the same workout routine six times over three weeks and wear a continuous glucose monitor to track changes.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include low or high blood sugar levels due to exercise-induced changes in glucose metabolism. Muscle soreness and fatigue are common after resistance training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Capillary glucose (change during exercise)
Secondary outcome measures
CGM coefficient of variation (CV)
CGM standard deviation (SD)
Mean CGM glucose
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment2 Interventions
There is only one study arm consisting of all participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fasted morning resistance exercise
2021
N/A
~30
Afternoon resistance exercise
2021
N/A
~30
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
888 Previous Clinical Trials
384,931 Total Patients Enrolled
DexCom, Inc.Industry Sponsor
137 Previous Clinical Trials
29,823 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have serious nerve damage in your arms or legs.You have changed how you manage your insulin in the past two months.Your blood pressure is higher than 140 over 95.You are between 18 and 55 years old.Your HbA1c level is higher than 9.9%.You are using a closed-loop insulin delivery system.You often have low blood sugar without warning.You have had heart or blood vessel problems in the past.You have had type 1 diabetes for at least 1 year.You have severe retinopathy that is getting worse.You have injuries that would make it unsafe for you to do resistance exercise.
Research Study Groups:
This trial has the following groups:- Group 1: All participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can individuals aged 60 or older enroll in this research study?
"This trial has a strict age range, with eligible participants being 18 years old or older and no older than 55."
Answered by AI
Who has the opportunity to participate in this research endeavor?
"A diabetes diagnosis and a diagnosis of an autoimmune disorder are the two primary criteria for admission into this trial. Patients must also be between 18 and 55 years old in order to qualify, with approximately 15 slots available overall."
Answered by AI
Is this research initiative accepting new participants?
"Based on the details present at clinicaltrials.gov, this medical experiment is actively seeking volunteers. It was uploaded to the website on November 16th 2021 and most recently revised January 10th 2022."
Answered by AI
How many participants are there in this experiment?
"Affirmative. Accessible on the clinicaltrials.gov website, this medical trial was first posted on 16th November 2021 and is still actively recruiting participants. The study requires 15 test subjects from a single experimental site for evaluation purposes."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger